| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8225570 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 6 Pages |
Abstract
These results suggest that clinically detectable BCRL will develop after traditional BCT in up to 10% of patients. High-risk subgroups include patients with advanced nodal status, those with more nodes removed, and those who receive chemotherapy, with patients receiving regional irradiation showing a trend toward increased rates.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Chirag M.D., John Ben M.D., Andrew M.D., Mihai M.D., Justin M.D., Nayana M.D., Savitha M.D., Christina R.N., Michelle R.N., Frank M.D.,